| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1572-0241.2000.02265.X |
| P698 | PubMed publication ID | 10950053 |
| P2093 | author name string | de Man RA | |
| Hop WC | |||
| Schalm SW | |||
| Hartmann IJ | |||
| Groeneweg M | |||
| Quero JC | |||
| Beijeman SJ | |||
| P433 | issue | 8 | |
| P921 | main subject | hepatic encephalopathy | Q642548 |
| P304 | page(s) | 2029-2034 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | The prognostic significance of subclinical hepatic encephalopathy | |
| P478 | volume | 95 |
| Q55496526 | Abnormal Regional Homogeneity and Functional Connectivity of Baseline Brain Activity in Hepatitis B Virus-Related Cirrhosis With and Without Minimal Hepatic Encephalopathy. |
| Q37798193 | Advances in the evaluation and management of minimal hepatic encephalopathy |
| Q44225011 | Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy. |
| Q34584902 | Ascites and encephalopathy in chronic liver disease |
| Q34224817 | Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy |
| Q36051082 | Association between road accidents and low-grade hepatic encephalopathy among Sri Lankan drivers with cirrhosis: a prospective case control study |
| Q37554174 | Cerebral Hemodynamics and Cognitive Function in Cirrhotic Patients with Hepatic Encephalopathy |
| Q35956338 | Characteristics of minimal hepatic encephalopathy |
| Q35888932 | Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy |
| Q90656510 | Clinical management of type C hepatic encephalopathy |
| Q28081300 | Clinical neurophysiology of hepatic encephalopathy |
| Q40895548 | Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy. |
| Q36699185 | Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy. |
| Q35064105 | Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization |
| Q35651383 | Detecting minimal hepatic encephalopathy in an endemic country for hepatitis B: the role of psychometrics and serum IL-6. |
| Q79972015 | Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis |
| Q57749807 | Diagnosis and Prognostic Significance of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver |
| Q48767753 | Distinguishing between clinical and minimal hepatic encephalopathy on the basis of specific cognitive impairment |
| Q40706904 | Dopamine from cirrhotic liver contributes to the impaired learning and memory ability of hippocampus in minimal hepatic encephalopathy |
| Q38237581 | Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis: an updated meta-analysis of six randomized controlled trials. |
| Q38219286 | Elevated cerebral lactate: Implications in the pathogenesis of hepatic encephalopathy |
| Q87416507 | Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver |
| Q26852922 | Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases |
| Q42730495 | Hepatic encephalopathy therapy: An overview |
| Q38199095 | Hepatic encephalopathy: early diagnosis in pediatric patients with cirrhosis |
| Q33436461 | Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy |
| Q35964960 | Impact of Hepatitis C Virus Infection on Cognitive Function in Patients With Covert Hepatic Encephalopathy |
| Q91655867 | Impact of minimal/covert hepatic encephalopathy on patients with cirrhosis |
| Q44074809 | Impairment of psychomotor responses after conscious sedation in cirrhotic patients undergoing therapeutic upper GI endoscopy |
| Q37613252 | Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver |
| Q36702499 | Inhibitory control test, critical flicker frequency, and psychometric tests in the diagnosis of minimal hepatic encephalopathy in cirrhosis |
| Q92522263 | KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications |
| Q36020921 | Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction |
| Q48217191 | MR imaging of the brain in patients with hepatic form of Wilson's disease |
| Q38515281 | Management of covert hepatic encephalopathy |
| Q37142443 | Meta-analysis: The diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy |
| Q35956343 | Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach |
| Q35642834 | Minimal hepatic encephalopathy impairs quality of life. |
| Q36404873 | Minimal hepatic encephalopathy in patients with cirrhosis by measuring liver stiffness and hepatic venous pressure gradient. |
| Q37376489 | Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test |
| Q42669850 | Minimal hepatic encephalopathy matters in daily life |
| Q53101224 | Minimal hepatic encephalopathy. |
| Q81393205 | Motor dysfunction in patients with liver cirrhosis: impairment of handwriting |
| Q35777723 | Multidimensional assessment of neuro-psychiatric symptoms in patients with low-grade hepatic encephalopathy: a clinical rating scale |
| Q42144821 | Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients |
| Q36355354 | Neurophysiological investigation of hepatic encephalopathy. |
| Q37468546 | Pharmacological manipulation of cyclic GMP levels in brain restores learning ability in animal models of hepatic encephalopathy: therapeutic implications. |
| Q44333628 | Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests |
| Q33666082 | Predictive value of POSSUM score in surgery of acute abdomen in cirrhotic patients |
| Q34411993 | Predictors of minimal hepatic encephalopathy in patients with cirrhosis |
| Q43860557 | Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients |
| Q90086720 | Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Cross-Sectional, Clinicoepidemiological, Multicenter, Nationwide Study in India: The PREDICT Study |
| Q89070694 | Prevalence of and Factors Associated With Minimal Hepatic Encephalopathy in Patients With Cirrhosis of Liver |
| Q36076561 | Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China |
| Q44825285 | Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. |
| Q60929935 | Quality of life in patients with minimal hepatic encephalopathy |
| Q33688130 | The Treatment of Patients With Hepatic Encephalopathy: Review of the Latest Data from EASL 2010 |
| Q50532497 | The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies. |
| Q87431760 | Treatment options for covert hepatic encephalopathy |
| Q36784836 | Update on the management of cirrhosis - focus on cost-effective preventative strategies |
| Q80060307 | Value of the critical flicker frequency in patients with minimal hepatic encephalopathy |
Search more.